Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia

Leukemia Research

Volumn 33, Issue 1, 2009, Pages 162-165

  Molica, Stefano ^a   Digiesi, Giovanna ^b   Mauro, Francesca ^c   Mirabelli, Rosanna ^a   Cutrona, Giovanna ^d   Vitelli, Gaetano ^b   Morabito, Fortunato ^e   Iuliano, Francesco ^f   Foà, Robin ^c   Ferrarini, Manlio ^d  

^a PUGLIESE CIACCIO HOSPITAL   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e Hematology Department   (Italy)

^f Ospedale Giannettasio   (Italy)

Author keywords

BAFF; Familial CLL; Prognosis

Indexed keywords

B CELL ACTIVATING FACTOR; IMMUNOGLOBULIN; PROTEIN KINASE ZAP 70;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FAMILIAL CANCER; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; B-CELL ACTIVATING FACTOR; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED;

EID: 55049131371     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.05.004     Document Type: Article

References (8)

1. Moore P.A., Belvedere O., Orr A., Pieri K., LaFleur D.W., Feng P., et al. BlyS member of tumor necrosis factor family and B lymphocyte stimulator. Science 285 (1999) 260-263
2. Cutrona G., Colombo M., Matis S., Reverberi D., Dono M., Tarantino V., et al. Lymphocytes in humans express ZAP-70 when activated in vivo. Eur J Immunol 36 (2006) 558-569
3. Batten M., Fletcher C., Ng L.G., Groom J., Wheway J., Laâbi Y., et al. TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma. J Immunol 172 (2004) 812-822
4. Haiat S., Billard C., Quiney C., Ajchenbaum-Cymbalista F., and Kolb J.P. Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia. Immunology 118 (2006) 281-292
5. Planelles L., Castillo-Gutiérrez S., Medema J.P., Morales-Luque A., Merle-Béral H., and Hahne M. APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival. Haematologica 92 (2007) 1284-1285
6. Novak A.J., Grote D.M., Ziesmer S.C., Kline M.P., Manske M.K., Slager S., et al. Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders. J Clin Oncol 24 (2006) 983-987
7. Goldin L.R., and Slager S.L. Familial CLL: genes and environment. Hematology (2007) 339-345 (Am Soc Hematol Educ Program 2007)
8. Byrd J.C. BAFF and related proteins: a new therapeutic target for B-cell malignancies. Blood 103 (2004) 372-373